Mobile Site ›

Test ID: CTSA    
Ceramide Trihexosides and Sulfatides, Urine

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Useful For Suggests clinical disorders or settings where the test may be helpful

Identifying patients with Fabry disease

 

Identifying patients with metachromatic leukodystrophy

 

Identifying patients with saposin B deficiency

 

Identifying patients with multiple sulfatase deficiency

 

Identifying patients with mucolipidosis II (I-cell disease)

Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request

 

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.

See Fabry Disease Testing Algorithm in Special Instructions.

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

Ceramide Trihex and Sulfatide, U

Aliases Lists additional common names for a test, as an aid in searching

Alpha-Galactosidase Deficiency
Arylsulfatase A Deficiency
Ceramide Hexosides
Ceramide Trihexosidase
Ceramide Trihexosidase Deficiency
Cerebrosides
Diffuse Angiokeratoma
Fabry's Disease
GB3
GL3
Globotriaosylceramide
Lipid Survey
Metachromatic Leukodystrophy
Fabry Disease